Characterization and Use of an Antibody Detecting the CBFβ-SMMHC Fusion Protein in inv(16)/t(16;16)-Associated Acute Myeloid Leukemias
David S. Viswanatha(Mayo Clinic), Cheryl L. Willman(Mayo Clinic), Pu Paul Liu(National Institutes of Health), David R. Head(University of Southern California), Cathy Rankin(National Institutes of Health), Marilyn L. Slovak(City Of Hope National Medical Center), I.-Ming Chen(National Human Genome Research Institute)
Cited by 0
Related Papers
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Age and acute myeloid leukemia
|Blood|2006|1.4k
All-<i>trans</i>-Retinoic Acid in Acute Promyelocytic Leukemia
|New England Journal of Medicine|1997|1.1k